Increased RUNX1 mutations in breast cancer disease progression
Despite advances in screening, therapy and surveillance, breast cancer remains threatening to women. Worst, patients suffer from side effects of treatments and cancer cells become resistant. The emergence of RUNX1 in breast cancer has put it in a spotlight due to its roles in the disease progression...
Published in: | PATHOLOGY RESEARCH AND PRACTICE |
---|---|
Main Authors: | Ariffin, Nur Syamimi |
Format: | Article |
Language: | English |
Published: |
ELSEVIER GMBH
2024
|
Subjects: | |
Online Access: | https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001164317100001 |
Similar Items
-
Increased RUNX1 mutations in breast cancer disease progression
by: Ariffin N.S.
Published: (2024) -
Mitochondrial DNA mutations in Malaysian female breast cancer patients
by: Omasanggar R.; Yu C.Y.; Ang G.Y.; Emran N.A.; Kitan N.; Baghawi A.; Ahmad A.F.; Abdullah M.A.; Teh L.K.; Maniam S.
Published: (2020) -
Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations
by: Abuhamad A.Y.; Mohamad Zamberi N.N.; Sheen L.; Naes S.M.; Mohd Yusuf S.N.H.; Ahmad Tajudin A.; Mohtar M.A.; Amir Hamzah A.S.; Syafruddin S.E.
Published: (2022) -
Evaluating the effect of RUNX1/ETO expression on mutagenesis at the NPM1 locus using flow cytometry
by: Ahid F.; Abd Rahman A.Z.; Ismail A.
Published: (2021) -
Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer
by: Liang Q.; Zhang S.; Liu J.; Zhou X.; Syamimi Ariffin N.; Wei J.; Shi C.; Ma X.; Zhang Y.; Huang R.
Published: (2024)